LV11992B - METALPIROLIDINYL METHYL ALLEGAL SALT - Google Patents
METALPIROLIDINYL METHYL ALLEGAL SALT Download PDFInfo
- Publication number
- LV11992B LV11992B LVP-97-256A LV970256A LV11992B LV 11992 B LV11992 B LV 11992B LV 970256 A LV970256 A LV 970256A LV 11992 B LV11992 B LV 11992B
- Authority
- LV
- Latvia
- Prior art keywords
- salt
- fumarate
- compound
- fumarate salt
- ylmethyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
- Pyrrole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9510223.2A GB9510223D0 (en) | 1995-05-20 | 1995-05-20 | Therapeutic agent |
PCT/EP1996/001560 WO1996036632A1 (en) | 1995-05-20 | 1996-04-10 | Pyrrolidinyl methyl indole salt |
Publications (2)
Publication Number | Publication Date |
---|---|
LV11992A LV11992A (lv) | 1998-03-20 |
LV11992B true LV11992B (en) | 1998-06-20 |
Family
ID=10774766
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LVP-97-256A LV11992B (en) | 1995-05-20 | 1997-12-11 | METALPIROLIDINYL METHYL ALLEGAL SALT |
Country Status (42)
Country | Link |
---|---|
US (1) | US5994387A (ko) |
EP (1) | EP0827503B1 (ko) |
JP (1) | JP3233940B2 (ko) |
KR (1) | KR100295255B1 (ko) |
CN (1) | CN1063175C (ko) |
AP (1) | AP738A (ko) |
AR (1) | AR003949A1 (ko) |
AT (1) | ATE194986T1 (ko) |
AU (1) | AU701154B2 (ko) |
BG (1) | BG63046B1 (ko) |
BR (1) | BR9610858A (ko) |
CA (1) | CA2219631C (ko) |
CO (1) | CO5040221A1 (ko) |
CZ (1) | CZ287939B6 (ko) |
DE (1) | DE69609504T2 (ko) |
DK (1) | DK0827503T3 (ko) |
DZ (1) | DZ2034A1 (ko) |
ES (1) | ES2148753T3 (ko) |
GB (1) | GB9510223D0 (ko) |
GR (1) | GR3034290T3 (ko) |
HK (1) | HK1017884A1 (ko) |
HR (1) | HRP960223B1 (ko) |
HU (1) | HU217657B (ko) |
IL (1) | IL118239A (ko) |
IS (1) | IS1908B (ko) |
LV (1) | LV11992B (ko) |
MA (1) | MA23876A1 (ko) |
MX (1) | MX9708966A (ko) |
MY (1) | MY132066A (ko) |
NO (1) | NO312068B1 (ko) |
NZ (1) | NZ306448A (ko) |
OA (1) | OA10747A (ko) |
PL (1) | PL183142B1 (ko) |
PT (1) | PT827503E (ko) |
RU (1) | RU2161618C2 (ko) |
SK (1) | SK281782B6 (ko) |
TN (1) | TNSN96074A1 (ko) |
TR (1) | TR199701397T1 (ko) |
UA (1) | UA44320C2 (ko) |
WO (1) | WO1996036632A1 (ko) |
YU (1) | YU29496A (ko) |
ZA (1) | ZA963938B (ko) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9825988D0 (en) * | 1998-11-27 | 1999-01-20 | Pfizer Ltd | Indole derivatives |
US20100266638A1 (en) * | 2004-02-26 | 2010-10-21 | Allergan, Inc. | Headache treatment method |
EP2875020B1 (en) * | 2012-07-19 | 2017-09-06 | Boehringer Ingelheim International GmbH | Process for the preparation of a fumaric acid salt of 9-[4-(3-chloro-2-fluoro-phenylamino)-7-methoxy- chinazolin-6-yloxy]-1,4-diaza-spiro[5.5]undecan-5-one |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3906406C1 (ko) * | 1989-03-01 | 1990-10-25 | Goedecke Ag, 1000 Berlin, De | |
DE9190141U1 (de) * | 1990-10-15 | 1993-07-15 | Pfizer Inc., New York, N.Y. | Indolderivate |
US5545644A (en) * | 1990-10-15 | 1996-08-13 | Pfizer Inc. | Indole derivatives |
AP486A (en) * | 1993-04-27 | 1996-04-16 | Pfizer | Indole derivatives. |
-
1995
- 1995-05-20 GB GBGB9510223.2A patent/GB9510223D0/en active Pending
-
1996
- 1996-04-10 CA CA002219631A patent/CA2219631C/en not_active Expired - Fee Related
- 1996-04-10 JP JP53448896A patent/JP3233940B2/ja not_active Expired - Fee Related
- 1996-04-10 HU HU9801761A patent/HU217657B/hu not_active IP Right Cessation
- 1996-04-10 PT PT96912013T patent/PT827503E/pt unknown
- 1996-04-10 MX MX9708966A patent/MX9708966A/es not_active IP Right Cessation
- 1996-04-10 EP EP96912013A patent/EP0827503B1/en not_active Expired - Lifetime
- 1996-04-10 WO PCT/EP1996/001560 patent/WO1996036632A1/en active IP Right Grant
- 1996-04-10 BR BR9610858A patent/BR9610858A/pt not_active Application Discontinuation
- 1996-04-10 TR TR97/01397T patent/TR199701397T1/xx unknown
- 1996-04-10 PL PL96323143A patent/PL183142B1/pl unknown
- 1996-04-10 CN CN96194043A patent/CN1063175C/zh not_active Expired - Fee Related
- 1996-04-10 CZ CZ19973648A patent/CZ287939B6/cs not_active IP Right Cessation
- 1996-04-10 SK SK1541-97A patent/SK281782B6/sk unknown
- 1996-04-10 RU RU97120998/04A patent/RU2161618C2/ru not_active IP Right Cessation
- 1996-04-10 UA UA97126158A patent/UA44320C2/uk unknown
- 1996-04-10 DK DK96912013T patent/DK0827503T3/da active
- 1996-04-10 US US08/952,792 patent/US5994387A/en not_active Expired - Fee Related
- 1996-04-10 AU AU55005/96A patent/AU701154B2/en not_active Ceased
- 1996-04-10 DE DE69609504T patent/DE69609504T2/de not_active Expired - Fee Related
- 1996-04-10 NZ NZ306448A patent/NZ306448A/xx unknown
- 1996-04-10 AT AT96912013T patent/ATE194986T1/de not_active IP Right Cessation
- 1996-04-10 ES ES96912013T patent/ES2148753T3/es not_active Expired - Lifetime
- 1996-04-10 KR KR1019970708280A patent/KR100295255B1/ko not_active IP Right Cessation
- 1996-04-11 AP APAP/P/1996/000801A patent/AP738A/en active
- 1996-05-10 AR ARP960102519A patent/AR003949A1/es unknown
- 1996-05-13 IL IL11823996A patent/IL118239A/xx not_active IP Right Cessation
- 1996-05-16 HR HR960223A patent/HRP960223B1/xx not_active IP Right Cessation
- 1996-05-16 YU YU29496A patent/YU29496A/sh unknown
- 1996-05-17 MA MA24243A patent/MA23876A1/fr unknown
- 1996-05-17 TN TNTNSN96074A patent/TNSN96074A1/fr unknown
- 1996-05-17 ZA ZA9603938A patent/ZA963938B/xx unknown
- 1996-05-17 MY MYPI96001888A patent/MY132066A/en unknown
- 1996-05-17 CO CO96025158A patent/CO5040221A1/es unknown
- 1996-05-18 DZ DZ960077A patent/DZ2034A1/fr active
-
1997
- 1997-10-30 IS IS4605A patent/IS1908B/is unknown
- 1997-11-13 NO NO19975210A patent/NO312068B1/no not_active IP Right Cessation
- 1997-11-18 BG BG102053A patent/BG63046B1/bg unknown
- 1997-11-20 OA OA70132A patent/OA10747A/en unknown
- 1997-12-11 LV LVP-97-256A patent/LV11992B/en unknown
-
1998
- 1998-10-20 HK HK98111337A patent/HK1017884A1/xx not_active IP Right Cessation
-
2000
- 2000-08-30 GR GR20000401977T patent/GR3034290T3/el not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO308999B1 (no) | Nye, kjemiske forbindelser, og farmasøytisk preparat inneholdende disse | |
CS228119B2 (en) | Production of n2-arylsulphonyl-l-argininamides | |
CA3066601C (en) | Pharmaceutically acceptable salt of alkylcarbamoyl naphthalenyloxy octenoylhydroxyamide or of derivative thereof and method for preparing same | |
EP4073036B1 (en) | Crystalline form of a 7h-benzo[7]annulene-2-carboxylic acid derivative | |
LV11992B (en) | METALPIROLIDINYL METHYL ALLEGAL SALT | |
AU657591B2 (en) | Stable salts of (+)-(1S,2R)-2-((N-(2-hydroxylamino-2-oxoethyl)-N-methyl- amino)carbonyl)cyclohexane-1-carboxylic acid, process for their preparation and pharmaceutical compositions containing them | |
KR880001865B1 (ko) | 4-(1-이미다졸일메틸)신남산 하이드로클로라이드 모노하이드레이트의 제조방법 | |
EA001363B1 (ru) | Кристаллический фармацевтический продукт | |
US10329264B2 (en) | Process for the preparation of isocarboxazid | |
US5744495A (en) | N, N-diethyl-8, 8-dipropyl-2-azaspiro 4.5! decane-2-propanamine | |
KR102209701B1 (ko) | 토파시티닙의 신규한 결정형 형태 및 이의 제조방법 | |
US20230382897A1 (en) | Crystalline form of lifitegrast, and pharmaceutical composition comprising the same | |
JP3062249B2 (ja) | ドーパミン再取込み阻害剤 | |
JP2010505900A (ja) | キマーゼ阻害剤としてのビニル酸誘導体 | |
WO2005023789A1 (en) | Phosphoric acid salt of (s)-(+)-2-ethoxy-4-{[3-methyl-1-(2-piperidin-1-yl-phenyl)-butylcarbamoyl]-methyl}-benzoic acid | |
WO2005023790A1 (en) | (s)-(+)-2-ethoxy-4-{[3-methyl-1-(2-piperidin-1-yl-phenyl)-butylcarbamoyl]-methyl}-benzoic acid sodium salt |